Previous Article | Next Article 
Journal of Clinical Microbiology, February 1998, p. 449-452, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Comparison of PCR, Isoenzyme Analysis, and Antigen Detection
for Diagnosis of Entamoeba histolytica
Infection
Rashidul
Haque,1
I. K. M.
Ali,1
S.
Akther,1 and
William A.
Petri Jr.2,*
International Centre for Diarrheal Disease
Research, Dhaka, Bangladesh,1 and
Departments of Medicine, Microbiology, and Pathology,
University of Virginia, Charlottesville, Virginia2
Received 19 August 1997/Returned for modification 21 October
1997/Accepted 4 November 1997
 |
ABSTRACT |
The diagnosis of amebiasis by microscopic identification of the
parasite in stool is insensitive and unable to distinguish the invasive
parasite Entamoeba histolytica from the commensal parasite E. dispar. In this study, we have tested a PCR
technique for the detection of E. histolytica and compared
it with isoenzyme analysis and the TechLab E. histolytica-specific antigen detection test. The nested-PCR test
we used is based on amplification of the small subunit rRNA gene of
E. histolytica and E. dispar followed by
restriction digest analysis of the PCR product. Single stool samples
were obtained from 98 patients from Dhaka, Bangladesh, with diarrhea:
88 patients diagnosed by microscopy and/or culture with E. histolytica and/or E. dispar infection and 10 patients without infection. Isoenzyme analysis identified 53 of the
infections as E. histolytica and 28 as E. dispar. PCR and isoenzyme identification of E. histolytica agreed in 96% (51 of 53) of amebic cultures. PCR for
E. histolytica was negative in all 10 samples that were negative for E. histolytica by isoenzyme and antigen
detection. PCR and antigen detection had comparable sensitivities when
performed directly on fresh stool specimens, identifying 87% (46 of
53) and 85% (45 of 53), respectively, of E. histolytica
infections identified by isoenzyme analysis. The correlation of results
by antigen detection and PCR for identification of E. histolytica in stool was 93% (45 of 48 cases). Mixed infections
with E. histolytica and E. dispar were detected
by PCR in 14% (12 of 88) of cases. In conclusion, all three techniques
for specific identification of E. histolytica in fresh
stool showed excellent correlation. Only the TechLab E. histolytica antigen detection test was both rapid and technically
simple.
 |
INTRODUCTION |
It has long been known that although
about 500 million people each year have amebiasis, only about 10%
experience symptomatic disease (20, 21). After much research
and argument, it is now generally accepted that what was earlier known
as Entamoeba histolytica actually comprises two
genetically distinct but morphologically indistinguishable species
a
pathogenic one, for which it has been suggested that the name
E. histolytica be retained, and a nonpathogenic one,
for which the name Entamoeba dispar has been revived
(4, 21). E. histolytica can cause invasive
intestinal and extraintestinal disease, while E. dispar cannot. A WHO-Pan American Health Organization-United Nations Educational, Scientific, and Cultural Organization Expert Panel
recently recommended the development of improved methods, using
technologies appropriate for developing countries, for the specific
diagnosis of E. histolytica infection (21).
Identification and differentiation of E. dispar and
E. histolytica in stool sample by microscopy is
imprecise. While E. histolytica trophozoites are more
likely than E. dispar to contain ingested erythrocytes, the organisms are identical in appearance
(4-6). Not only is microscopy unable to differentiate
E. histolytica from E. dispar; it
is at best only 60% sensitive and can be confounded by false-positive
results due to misidentification of macrophages and nonpathogenic
species of Entamoeba (6, 9, 11, 17). Culture
is more sensitive than microscopy, and isoenzyme analysis of cultured
amebae enables the differentiation of E. histolytica from E. dispar. However, amebic cultures and
isoenzyme analysis require a week to complete and are negative in many
microscopy-positive samples, in some cases due to delays in sample
processing or due to the institution of antiamebic therapy prior to
stool collection (6, 9, 17).
New approaches to the detection of E. histolytica and
E. dispar are based on antigen detection in
stool (1, 7-9, 17) and detection of E. histolytica-specific DNA by PCR amplification (2, 3, 10, 13,
16, 18). Antigenic differences in the lectin of
E. histolytica and E. dispar
amebae enable specific identification of the disease-causing amebae
E. histolytica (14). Antigen detection tests
have proven to be more sensitive and specific than microscopy
(7-9). In this study, we have used a PCR technique for
detection of E. histolytica and compared it with
antigen detection and isoenzyme analysis.
 |
MATERIALS AND METHODS |
Stool specimens.
Stool samples were collected from patients
with diarrhea seen in 1995 and 1996 at the International Center for
Diarrheal Disease Research, Bangladesh (ICDDR,B). Analyzed were single
stool samples from 88 patients diagnosed with E. histolytica and/or E. dispar infection (by
microscopy and/or culture) and from 10 patients whose stool samples
were negative by microscopy and culture for E. histolytica and E. dispar infection.
Antigen detection, culture, and isoenzyme analyses.
The
TechLab (Blacksburg, Va.) Entamoeba test (designed to
detect but not differentiate E. histolytica and
E. dispar antigen in stool specimens) and TechLab
E. histolytica test (designed to detect specifically
E. histolytica in stool specimens) were performed on
the stool specimens according to the manufacturer's instructions.
Fresh stool samples were examined microscopically in a 0.9% saline
smear for the presence of E. histolytica-E.
dispar complex cysts and trophozoites. Stools were cultured
for Entamoeba species in Robinson's medium within
6 h of collection, and isoenzyme analysis was performed as
described previously (7, 15).
Extraction of DNA from stool samples and cultures.
Trophozoites and cysts present in the stool and cultured amebae from
the stool samples were the source of target DNA, which was purified by
a modified version of the method of Katzwinkel-Wladarsch et al.
(10). All procedures were performed with sterile, disposable plastic tubes and pipette tips. Aliquots (0.2 g) of stool samples or
cultures in Robinson's medium were taken to 1.5 ml in microcentrifuge tubes, and 33.3 µl of 1 M KOH and 9.3 µl of 1 M dithiothreitol were
added. The samples were mixed thoroughly by stirring with a pipette
tip, followed by brief shaking. After incubation at 65°C for 15 min,
the samples were neutralized with 4.3 µl of 25% HCl and buffered
with 80 µl of 2 M Tris-HCl (pH 8.3) and the suspension was mixed
again. The DNA was extracted by shaking with 250 µl of
phenol-chloroform-isoamyl alcohol (25:24:1) (PCI) saturated with 10 mM
Tris (pH 8.0) and 1 mM EDTA. The phases were separated by a 4-min spin
in a microcentrifuge. The aqueous phase was transferred to a new tube,
and the DNA was further purified by adsorption to 5 µl of Glassmax
matrix suspension (Gibco BRL). The DNA was eluted in 39 µl of
deionized water.
PCR method.
Primer construction was based on sequences from
the small subunit rRNA gene of E. histolytica and
E. dispar (10). For the first PCR, the
primer pair E-1 (TTT GTA TTA GTA CAA A) and E-2 (GTA
[A/G]TA TTG ATA TAC T), which amplified a 0.9 kb fragment of
the rRNA gene, was used. The primer pair E-1 and E-2 is complementary to both E. histolytica and E. dispar sequences, with the E-2 primer constructed twofold
degenerately, i.e., as a mixture with half corresponding to the
E. histolytica sequence and the other half corresponding to the E. dispar sequence. The first
PCR amplification with E-1 and E-2 was followed by two additional PCRs,
each of which was specific for either the E. histolytica or the E. dispar sequence. The
primers used for these reactions were located downstream of E-1 and
E-2, making this a nested PCR. For the second (nested) PCR, two
different primer pairs specific for E. histolytica
(EH-1, AAT GGC CAA TTC ATT CAA TG, and EH-2, TTT AGA
AAC AAT GCT TCT CT) or E. dispar (ED-1,
AGT GGC CAA TTT ATG TAA GT, and ED-2, TTT AGA AAC AAT GTT
TCT TC) were used. All primers were obtained from Oswel DNA,
University of Southampton, Southampton, United Kingdom.
Both of the PCRs used a hot-start technique. In the first PCR, 18.4 µl of the DNA extracts was denatured at 96°C for 2 min after the
addition of 0.6 µl each of 40 µM solutions of the primers (E-1 and
E-2) and 1 drop of mineral oil. After cooling to 80°C, 5.4 µl of
freshly prepared "mastermix" (2.5 µl of 10× PCR buffer [catalog
no. 18038; Gibco BRL], 2 µl of 50 mM MgCl2, 0.64 µl of deoxynucleoside triphosphate mix [10 mM each; Perkin-Elmer, Norwalk, Conn.], and 0.25 µl (5 IU/µl) of Taq polymerase [Gibco
BRL]) was added. Fifty cycles with denaturation at 92°C for 60 s, annealing at 43°C for 60 s, and extension at 72°C for
90 s were performed. In the second (nested) PCR, 3 µl of the
first PCR product was taken in 26 µl of water and denatured at 96°C
for 2 min after the addition of 1 µl each of 40 µM solutions of the
primers (EH-1 and EH-2 for E. histolytica; ED-1 and
ED-2 for E. dispar) and 2 drops of mineral oil.
After cooling to 80°C, 8.6 µl of freshly prepared mastermix (10×
PCR buffer, 3.2 µl of 50 mM MgCl2, 1 µl of
deoxynucleoside triphosphate mix, and 0.4 µl of Taq
polymerase) was added and PCR was performed as described above, except
that the annealing temperature was 62°C. PCR amplifications were
performed with a Bio-Rad gene cycler. Products were visualized on a
1.3% agarose gel containing ethidium bromide (0.2 µg/ml; Sigma).
Restriction endonuclease digests.
Bands excised from the
agarose gel were silica gel purified as described above, eluted in 9.6 µl of buffer, and digested with 0.8 µl (10 U/µl) of
DraI (Gibco BRL) for 60 min at 37°C, followed by the
addition of 0.4 µl (10 U/µl) of Sau96I (Amersham) and
further incubation at the same temperature for another 90 min, by the method of Katzwinkel-Wladarsch et al. (10).
 |
RESULTS |
The nested-PCR amplifications, performed by a modification of the
method of Katzwinkel-Wladarsch et al., yielded a 0.9-kb band with
E. histolytica and E. dispar DNA.
Restriction enzyme digestion of the DNA amplified with the
E. histolytica-specific primers exhibited
characteristic bands of 0.55 and 0.35 kb, usually with some of the
undigested 0.9-kb band remaining. The E. dispar-amplified DNA yielded a band of 0.55 kb and a confluent
band of 0.15 to 0.2 kb, often with a partial digestion product of 0.7 kb (Fig. 1).

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 1.
Restriction endonuclease digestion of the products of
nested PCR. The restriction fragments of DNA amplified with the
E. dispar-specific nested primers (lanes 1 and 3)
and E. histolytica-specific nested primers (lanes 2 and
4) are shown. The starting materials for the PCRs were stool samples
from patients with culture-confirmed infections with E. dispar (lane 1), E. histolytica (lane 2), and
E. histolytica (lanes 3 and 4 [a mixed infection based
on PCR]). The marker (lane M) is X174 DNA digested with
HaeIII.
|
|
Nested PCR, antigen detection tests, and culture and isoenzyme analyses
were performed on 98 stool specimens from patients with diarrhea in
Dhaka. Stool specimens from 68 patients were positive for E. histolytica and/or E. dispar infection by
microscopy and culture, 13 were positive only by culture, 7 were
positive only by microscopy, and 10 were negative by both microscopy
and culture (data not shown). Isoenzyme analysis identified 53 E. histolytica and 28 E. dispar
infections from the 81 culture-positive isolates. Nested PCR using
cultured amebae as the source of DNA demonstrated a 96% correlation
with isoenzyme analysis in detecting E. histolytica
infection: 51 of 53 isolates identified as E. histolytica by isoenzyme analysis demonstrated E. histolytica-specific DNA amplification products (data not shown).
Results of nested PCR using stool were compared with those of culture
and isoenzyme analysis (Table 1). For the
53 stool specimens that were positive for E. histolytica by isoenzyme analysis, the nested PCR performed
directly on stool was positive for 46 specimens (including 9 specimens
positive for both E. histolytica and E. dispar), for a correlation of 87% (Table
1). The PCR and antigen detection tests
had similar sensitivities when performed directly on stool specimens,
identifying 87% (46 of 53) and 85% (45 of 53), respectively, of
E. histolytica infections identified by culture and
isoenzyme analyses (data not shown).
Results of the nested PCR using stool specimens were also compared with
those of the antigen detection tests (Table
2). The antigen detection tests revealed
that there were 50 samples positive for E. histolytica,
29 positive for E. dispar, and 19 negative for
E. histolytica and E. dispar
antigens. For the 50 specimens that were positive for E. histolytica by the antigen detection tests, the nested PCR
performed directly on stool specimen was positive for 47 specimens
(including 8 specimens positive for both E. histolytica
and E. dispar), for a correlation of 94%. Out of
12 mixed infections of E. histolytica and E. dispar detected by the nested PCR performed directly on stool,
8 specimens were identified as E. histolytica by the
antigen detection test (Table 2).
 |
DISCUSSION |
Microscopy is an outmoded technique that should not be used to
diagnose amebic colitis: it is insensitive, incapable of
differentiating pathogenic E. histolytica from
nonpathogenic E. dispar, and prone to giving
false-positive results. Our experience in Bangladesh has highlighted
the danger of relying on microscopy. Of all children with diarrhea
diagnosed with amebiasis by microscopy, only 40% were proven to have
E. histolytica infection when specific methods (antigen
detection and culture-isoenzyme analysis) were used. And of all
children diagnosed with E. histolytica infection by specific methods, the majority were missed by microscopy
(9).
For this reason the WHO, the Pan American Health Organization, and
UNESCO issued in 1997 the joint recommendation that "E. histolytica should be specifically identified" (21).
The only E. histolytica-specific test that is approved
for in vitro diagnostic use is the TechLab E. histolytica antigen detection kit. The Alexon and Merlin Optimum S
antigen detection kit cross-react with E. dispar
(12).
This study represents the first time that three independent techniques
for species-specific identification of E. histolytica have been compared by using the same stool samples. The nested-PCR test
for detection of E. histolytica (based on amplification
of the rRNA gene) correlated well with antigen detection and isoenzyme techniques for detection of E. histolytica in diarrheal
stool specimens. The overall correlation between the nested-PCR results from stool specimens and those of antigen detection tests for detecting
E. histolytica infection was greater than 90%. This agreement between techniques provides confidence that any one of the
techniques may be used alone to yield an accurate assessment of the
presence of E. histolytica in a stool specimen.
However, of the three techniques, the TechLab antigen detection test
was by far the most rapid and simple, providing an answer within 2 to
3 h. In contrast, it took several days to complete the PCR test,
and 1 to 2 weeks were needed to culture the amebae and perform isoenzyme analysis.
PCR amplification of rRNA genes has been shown to be more sensitive
than antigen detection when cultured parasites are used as the source
of DNA and antigen (12). However, in the real-world situation where the parasite has to be identified in stool specimens, our results indicate that the two techniques are approximately equal in
sensitivity. Thus, there is no disadvantage to the use of antigen
detection and there is a decided advantage to its use due to its speed
and technical simplicity.
Dual infection with E. dispar and E. histolytica in the same stool specimen and occult infection
(PCR-detected infection in stool specimens negative for E. histolytica by other techniques) were both uncommon, similar to
the observations of other investigators studying smaller numbers of
samples (3, 19). This is a marked contrast to studies of
Mexican children by Samuelson and colleagues (13, 16), in
which PCR detected dual and occult infections in the majority of stool
specimens tested. This could reflect real differences in the
epidemiology of E. histolytica in Mexico and
Bangladesh. However, it is also possible that the PCR test used in the
Mexican studies (which was based on highly repetitive sequences in the
noncoding region of the rRNA gene) was prone to a high level of
false-positive results. Unfortunately, in the studies from Mexico the
PCR results were not confirmed by either culture or antigen detection.
In conclusion, the nested PCR described in the present work is
comparable to isoenzyme analysis and the TechLab E. histolytica antigen detection test for identifying E. histolytica infection in stool. However, the PCR technique
described is time-consuming, cumbersome, and expensive and therefore
not well suited for use in developing countries where amebiasis is
prevalent. The antigen detection test, which is rapid and simple and
does not require any special equipment, is presently the only practical
means for diagnosis of E. histolytica infection.
 |
ACKNOWLEDGMENTS |
This research was supported by National Institutes of Health
grant AI-26649 and the ICDDR,B. TechLab, Inc., provided the
E. histolytica antigen detection kits. The ICDDR,B is
supported by countries and agencies which share its concern for the
health problems of developing countries. Current donors include the aid agencies of the governments of Australia, Bangladesh, Belgium, Canada,
China, Germany, Japan, The Netherlands, Norway, Republic of Korea,
Saudi Arabia, Sweden, Switzerland, the United Kingdom, and the United
States; international organizations, including the Arab Gulf Fund, the
Asian Development Bank, the International Atomic Energy Center, the
United Nations Children's Fund (UNICEF), the United Nations
Development Program (UNDP), the United Nations Population Fund (UNFPA),
and the WHO; private foundations, including the Child Health
Foundation, the Ford Foundation, the Population Council, the
Rockefeller Foundation, and the Sasakawa Foundation; and private
organizations, including American Express Bank, Bayer AG, CARE, Family
Health International, Helen Keller International, the Johns Hopkins
University, Procter Gamble, RAND, SANDOZ, Swiss Red Cross, the
University of California, Davis, and others.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Room 2115 MR4
Building, University of Virginia Health Sciences Center,
Charlottesville, VA 22908. Phone: (804) 924-5621. Fax: (804) 924-0075. E-mail: wap3g{at}virginia.edu.
 |
REFERENCES |
| 1.
|
Abd-Alla, M. D.,
T. F. H. G. Jackson,
V. Gathiram,
A. M. El-Hawey, and J. I. Ravdin.
1993.
Differentiation of pathogenic Entamoeba histolytica infections from nonpathogenic infections by detection of galactose-inhibitable adherence protein antigen in sera and feces.
J. Clin. Microbiol.
31:2845-2850[Abstract/Free Full Text].
|
| 2.
|
Acuna-Soto, R.,
J. Samuelson,
P. De Girolami, et al.
1994.
Application of the polymerase chain reaction to the epidemiology of pathogenic and nonpathogenic Entamoeba histolytica.
Am. J. Trop. Med. Hyg.
48:58-70.
|
| 3.
|
Britten, D.,
S. M. Wilson,
R. McNerney,
A. H. Moody,
P. L. Chiodini, and J. P. Ackers.
1997.
An improved colorimetric PCR-based method for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces.
J. Clin. Microbiol.
35:1108-1111[Abstract].
|
| 4.
|
Diamond, L. S., and C. G. Clark.
1993.
A redescription of Entamoeba histolytica Shaudinn 1903 (amended Walker 1911) separating it from Entamoeba dispar (Brumpt 1925).
J. Eukaryot. Microbiol.
40:340-344[Medline].
|
| 5.
|
Gathiram, V., and T. F. H. G. Jackson.
1985.
Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population.
Lancet.
i:719-721.
|
| 6.
|
Gonzalez-Ruiz, A.,
R. Haque,
A. Aguirre, et al.
1994.
Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica.
J. Clin. Pathol.
47:236-239[Abstract/Free Full Text].
|
| 7.
|
Haque, R.,
K. Kress,
S. Wood, et al.
1993.
Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose specific adhesin.
J. Infect. Dis.
167:247-249[Medline].
|
| 8.
|
Haque, R.,
L. M. Neville,
P. Hahn, and W. A. Petri, Jr.
1995.
Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits.
J. Clin. Microbiol.
33:2558-2561[Abstract].
|
| 9.
|
Haque, R.,
A. S. G. Faruque,
P. Hahn,
D. M. Lyerly, and W. A. Petri, Jr.
1997.
Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh.
J. Infect. Dis.
175:734-736[Medline].
|
| 10.
|
Katzwinkel-Wladarsch, S.,
T. Loscher, and H. Rinder.
1994.
Direct amplification and differentiation of pathogenic and nonpathogenic Entamoeba histolytica DNA from stool specimens.
Am. J. Trop. Med. Hyg.
51:115-118.
|
| 11.
|
Krogstad, D. J.,
H. C. Spencer,
G. R. Healy, et al.
1978.
Amebiasis: epidemiologic studies in the United States, 1971-1974.
Ann. Intern. Med.
88:89-97.
|
| 12.
|
Mirelman, D.,
Y. Nuchamowitz, and T. Stolarsky.
1997.
Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar.
J. Clin. Microbiol.
35:2405-2407[Abstract].
|
| 13.
|
Newton-Sanchez, O. A.,
K. Sturm-Ramirez,
J. L. Romero-Zamora,
J. I. Santos-Preciado, and J. Samuelson.
1997.
High rate of occult infection with Entamoeba histolytica among non-dysenteric Mexican children.
Arch. Med. Res.
28:S311-S313.
|
| 14.
|
Petri, W. A., Jr.,
T. F. H. G. Jackson,
V. Gathiram,
K. Kress,
L. D. Saffer,
T. L. Snodgrass,
M. D. Chapman,
Z. Keren, and D. Mirelman.
1990.
Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin.
Infect. Immun.
58:1802-1806[Abstract/Free Full Text].
|
| 15.
|
Robinson, G. L.
1968.
The laboratory diagnosis of human parasitic amoebae.
Trans. R. Soc. Trop. Med. Hyg.
62:285-294[Medline].
|
| 16.
|
Romero, J. L.,
S. Descoteaux,
S. Reed,
E. Orozco,
J. Santos, and J. Samuelson.
1992.
Use of polymerase chain reaction and nonradioactive DNA probes to diagnose Entamoeba histolytica in clinical samples.
Arch. Med. Res.
23:277-279[Medline].
|
| 17.
|
Strachan, W. D.,
W. M. Spice,
P. L. Chiodini,
A. H. Moody, and J. P. Ackers.
1988.
Immunological differentiation of pathogenic and nonpathogenic isolates of E. histolytica.
Lancet
i:561-563.
|
| 18.
|
Tannich, E., and G. D. Burchard.
1991.
Differentiation of pathogenic from nonpathogenic Entamoeba histolytica by restriction fragment analysis of a single gene amplified in vitro.
J. Clin. Microbiol.
29:250-255[Abstract/Free Full Text].
|
| 19.
|
Troll, H.,
H. Marti, and N. Weiss.
1997.
Simple differential detection of Entamoeba histolytica and Entamoeba dispar in fresh stool specimens by sodium acetate-acetic acid-formalin concentration and PCR.
J. Clin. Microbiol.
35:1701-1705[Abstract].
|
| 20.
|
Walsh, J. A.
1986.
Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.
Rev. Infect. Dis.
8:228-238[Medline].
|
| 21.
|
World Health Organization.
1997.
Amoebiasis.
W. H. O. Weekly Epidemiol. Rec.
72:97-100.
|
Journal of Clinical Microbiology, February 1998, p. 449-452, Vol. 36, No. 2
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
de Saussure, P. P. H.
(2009). Review: Management of the returning traveler with diarrhea. Therapeutic Advances in Gastroenterology
2: 367-375
[Abstract]
-
Liang, S.-Y., Chan, Y.-H., Hsia, K.-T., Lee, J.-L., Kuo, M.-C., Hwa, K.-Y., Chan, C.-W., Chiang, T.-Y., Chen, J.-S., Wu, F.-T., Ji, D.-D.
(2009). Development of Loop-Mediated Isothermal Amplification Assay for Detection of Entamoeba histolytica. J. Clin. Microbiol.
47: 1892-1895
[Abstract]
[Full Text]
-
Buss, S., Kabir, M., Petri, W. A. Jr., Haque, R.
(2008). Comparison of Two Immunoassays for Detection of Entamoeba histolytica. J. Clin. Microbiol.
46: 2778-2779
[Abstract]
[Full Text]
-
Stark, D., van Hal, S., Fotedar, R., Butcher, A., Marriott, D., Ellis, J., Harkness, J.
(2008). Comparison of Stool Antigen Detection Kits to PCR for Diagnosis of Amebiasis. J. Clin. Microbiol.
46: 1678-1681
[Abstract]
[Full Text]
-
Fotedar, R., Stark, D., Beebe, N., Marriott, D., Ellis, J., Harkness, J.
(2007). Laboratory Diagnostic Techniques for Entamoeba Species. Clin. Microbiol. Rev.
20: 511-532
[Abstract]
[Full Text]
-
HAQUE, R., ROY, S., SIDDIQUE, A., MONDAL, U., RAHMAN, S. M. M., MONDAL, D., HOUPT, E., PETRI, W. A. JR
(2007). MULTIPLEX REAL-TIME PCR ASSAY FOR DETECTION OF ENTAMOEBA HISTOLYTICA, GIARDIA INTESTINALIS, AND CRYPTOSPORIDIUM SPP.. Am J Trop Med Hyg
76: 713-717
[Abstract]
[Full Text]
-
TANYUKSEL, M., ULUKANLIGIL, M., GUCLU, Z., ARAZ, E., KORU, O., PETRI, W. A. JR.
(2007). TWO CASES OF RARELY RECOGNIZED INFECTION WITH ENTAMOEBA MOSHKOVSKII. Am J Trop Med Hyg
76: 723-724
[Abstract]
[Full Text]
-
STARK, D., FOTEDAR, R., VAN HAL, S., BEEBE, N., MARRIOTT, D., ELLIS, J. T., HARKNESS, J.
(2007). PREVALENCE OF ENTERIC PROTOZOA IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-POSITIVE AND HIV-NEGATIVE MEN WHO HAVE SEX WITH MEN FROM SYDNEY, AUSTRALIA. Am J Trop Med Hyg
76: 549-552
[Abstract]
[Full Text]
-
Leo, M., Haque, R., Kabir, M., Roy, S., Lahlou, R. M., Mondal, D., Tannich, E., Petri, W. A. Jr.
(2006). Evaluation of Entamoeba histolytica Antigen and Antibody Point-of-Care Tests for the Rapid Diagnosis of Amebiasis. J. Clin. Microbiol.
44: 4569-4571
[Abstract]
[Full Text]
-
Hamzah, Z., Petmitr, S., Mungthin, M., Leelayoova, S., Chavalitshewinkoon-Petmitr, P.
(2006). Differential Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii by a Single-Round PCR Assay.. J. Clin. Microbiol.
44: 3196-3200
[Abstract]
[Full Text]
-
SAMIE, A., OBI, L. C., BESSONG, P. O., STROUP, S., HOUPT, E., GUERRANT, R. L.
(2006). Prevalence and species distribution of e. Histolytica and e. Dispar in the venda region, limpopo, South Africa.. Am J Trop Med Hyg
75: 565-571
[Abstract]
[Full Text]
-
Ali, I. K. M., Zaki, M., Clark, C. G.
(2005). Use of PCR Amplification of tRNA Gene-Linked Short Tandem Repeats for Genotyping Entamoeba histolytica. J. Clin. Microbiol.
43: 5842-5847
[Abstract]
[Full Text]
-
Qvarnstrom, Y., James, C., Xayavong, M., Holloway, B. P., Visvesvara, G. S., Sriram, R., da Silva, A. J.
(2005). Comparison of Real-Time PCR Protocols for Differential Laboratory Diagnosis of Amebiasis. J. Clin. Microbiol.
43: 5491-5497
[Abstract]
[Full Text]
-
van Doorn, H. R., Hofwegen, H., Koelewijn, R., Gilis, H., Peek, R., Wetsteyn, J. C. F. M., van Genderen, P. J. J., Vervoort, T., van Gool, T.
(2005). Use of Rapid Dipstick and Latex Agglutination Tests and Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Amebic Liver Abscess, Amebic Colitis, and Entamoeba histolytica Cyst Passage. J. Clin. Microbiol.
43: 4801-4806
[Abstract]
[Full Text]
-
Bhattacharya, D., Haque, R., Singh, U.
(2005). Coding and Noncoding Genomic Regions of Entamoeba histolytica Have Significantly Different Rates of Sequence Polymorphisms: Implications for Epidemiological Studies. J. Clin. Microbiol.
43: 4815-4819
[Abstract]
[Full Text]
-
Roy, S., Kabir, M., Mondal, D., Ali, I. K. M., Petri, W. A. Jr., Haque, R.
(2005). Real-Time-PCR Assay for Diagnosis of Entamoeba histolytica Infection. J. Clin. Microbiol.
43: 2168-2172
[Abstract]
[Full Text]
-
Furrows, S J, Moody, A H, Chiodini, P L
(2004). Comparison of PCR and antigen detection methods for diagnosis of Entamoeba histolytica infection. J. Clin. Pathol.
57: 1264-1266
[Abstract]
[Full Text]
-
Tanyuksel, M., Petri, W. A. Jr.
(2003). Laboratory Diagnosis of Amebiasis. Clin. Microbiol. Rev.
16: 713-729
[Abstract]
[Full Text]
-
Haque, R., Huston, C. D., Hughes, M., Houpt, E., Petri, W. A. Jr.
(2003). Amebiasis. NEJM
348: 1565-1573
[Full Text]
-
Gonin, P., Trudel, L.
(2003). Detection and Differentiation of Entamoeba histolytica and Entamoeba dispar Isolates in Clinical Samples by PCR and Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol.
41: 237-241
[Abstract]
[Full Text]
-
Zaki, M., Meelu, P., Sun, W., Clark, C. G.
(2002). Simultaneous Differentiation and Typing of Entamoeba histolytica and Entamoeba dispar. J. Clin. Microbiol.
40: 1271-1276
[Abstract]
[Full Text]
-
Yau, Y. C. W., Crandall, I., Kain, K. C.
(2001). Development of Monoclonal Antibodies Which Specifically Recognize Entamoeba histolytica in Preserved Stool Samples. J. Clin. Microbiol.
39: 716-719
[Abstract]
[Full Text]
-
Sharp, S. E., Suarez, C. A., Duran, Y., Poppiti, R. J.
(2001). Evaluation of the Triage Micro Parasite Panel for Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in Patient Stool Specimens. J. Clin. Microbiol.
39: 332-334
[Abstract]
[Full Text]
-
Haque, R., Mollah, N. U., Ali, I. K. M., Alam, K., Eubanks, A., Lyerly, D., Petri, W. A. Jr.
(2000). Diagnosis of Amebic Liver Abscess and Intestinal Infection with the TechLab Entamoeba histolytica II Antigen Detection and Antibody Tests. J. Clin. Microbiol.
38: 3235-3239
[Abstract]
[Full Text]
-
Garcia, L. S., Shimizu, R. Y., Bernard, C. N.
(2000). Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum Antigens in Human Fecal Specimens Using the Triage Parasite Panel Enzyme Immunoassay. J. Clin. Microbiol.
38: 3337-3340
[Abstract]
[Full Text]
-
Que, X., Reed, S. L.
(2000). Cysteine Proteinases and the Pathogenesis of Amebiasis. Clin. Microbiol. Rev.
13: 196-206
[Abstract]
[Full Text]
-
Espinosa-Cantellano, M., Martinez-Palomo, A.
(2000). Pathogenesis of Intestinal Amebiasis: From Molecules to Disease. Clin. Microbiol. Rev.
13: 318-331
[Abstract]
[Full Text]
-
Pillai, D. R., Kain, K. C.
(1999). Immunochromatographic Strip-Based Detection of Entamoeba histolytica-E. dispar and Giardia lamblia Coproantigen. J. Clin. Microbiol.
37: 3017-3019
[Abstract]
[Full Text]
-
Braga, L. L., Mendonca, Y., Paiva, C. A., Sales, A., Cavalcante, A. L. M., Mann, B. J.
(1998). Seropositivity for and Intestinal Colonization with Entamoeba histolytica and Entamoeba dispar in Individuals in Northeastern Brazil. J. Clin. Microbiol.
36: 3044-3045
[Abstract]
[Full Text]